Who
Stephen D. Griffin
President and CEO
Company insider
Files Form 4 as: President and CEO, Anika Therapeutics; Senior Vice President and CFO, Vse.
In numbers
- Trades disclosed
- 67
- Buys
- 1
- Sells
- 0
- Bought
- $300K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 Nov 2020
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —12,840 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $54K3,769 at $14.41 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —12,840 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —12,840 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —12,840 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $54K3,769 at $14.41 | filing |
| 30 Apr 2026filed 30 Apr 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Bought | $150K12,200 at $12.29 | filing |
| 30 Apr 2026filed 30 Apr 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Bought | $150K12,200 at $12.29 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —12,824 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —6,412 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $84K5,944 at $14.20 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —12,824 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —12,824 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —12,824 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —6,412 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $84K5,944 at $14.20 | filing |
| 1 Feb 2026filed 3 Feb 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —310,207 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —130,402 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —310,207 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —130,402 at $0.00 | filing |
News
Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ANIK · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Stephen D. Griffin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.